JACQUELINE KLEE: Open Payments
NPI 1215028766 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 20 payments from 7 companies in 2025. Trend: 2023 $1,411 · 2024 $1,129 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $178 |
| Teva Pharmaceuticals USA, Inc. | 2 | $125 |
| Alkermes, Inc. | 3 | $73 |
| Lundbeck LLC | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: CAPLYTA, UZEDY, ABILIFY ASIMTUFII, ARISTADA, VIVITROL, INVEGA SUSTENNA, Qelbree, REXULTI.
Industry payments across KY — which companies pay providers there.
